BR112022018268A2 - Cápsulas de softgel - Google Patents

Cápsulas de softgel

Info

Publication number
BR112022018268A2
BR112022018268A2 BR112022018268A BR112022018268A BR112022018268A2 BR 112022018268 A2 BR112022018268 A2 BR 112022018268A2 BR 112022018268 A BR112022018268 A BR 112022018268A BR 112022018268 A BR112022018268 A BR 112022018268A BR 112022018268 A2 BR112022018268 A2 BR 112022018268A2
Authority
BR
Brazil
Prior art keywords
softgel capsules
softgel
fill material
cover composition
capsules
Prior art date
Application number
BR112022018268A
Other languages
English (en)
Portuguese (pt)
Inventor
Steve SHELLEY Rickey
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of BR112022018268A2 publication Critical patent/BR112022018268A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
BR112022018268A 2020-03-18 2021-03-18 Cápsulas de softgel BR112022018268A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062991354P 2020-03-18 2020-03-18
PCT/US2021/022918 WO2021188773A1 (en) 2020-03-18 2021-03-18 Softgel capsules

Publications (1)

Publication Number Publication Date
BR112022018268A2 true BR112022018268A2 (pt) 2022-10-25

Family

ID=77771391

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018268A BR112022018268A2 (pt) 2020-03-18 2021-03-18 Cápsulas de softgel

Country Status (11)

Country Link
US (1) US20230172864A1 (enExample)
EP (1) EP4121036A4 (enExample)
JP (2) JP7785682B2 (enExample)
KR (1) KR20220154196A (enExample)
AR (1) AR121608A1 (enExample)
AU (1) AU2021238345A1 (enExample)
BR (1) BR112022018268A2 (enExample)
CA (1) CA3171512A1 (enExample)
CO (1) CO2022014130A2 (enExample)
MX (1) MX2022011549A (enExample)
WO (1) WO2021188773A1 (enExample)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
RU2359698C2 (ru) * 2002-09-13 2009-06-27 Сайдекс, Инк. Капсулы, содержащие водные наполняющие композиции, стабилизированные производным циклодекстрина
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
EP1802287A2 (en) * 2004-09-27 2007-07-04 Sigmoid Biotechnologies Limited Minicapsule formulations
CN1872061A (zh) * 2006-04-17 2006-12-06 宛六一 一种药物组合物软胶囊及其制备方法
JP5840668B2 (ja) * 2012-12-07 2016-01-06 富士カプセル株式会社 ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤
US10420729B2 (en) * 2013-03-15 2019-09-24 R.P. Scherer Technologies, Llc Abuse resistant capsule
US9326947B1 (en) * 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
US9867779B2 (en) * 2015-03-26 2018-01-16 Patheon Softgels Inc. Liquisoft capsules
AU2016247674A1 (en) * 2015-04-14 2017-10-19 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
AU2019236237B2 (en) * 2018-03-15 2024-12-05 R.P. Scherer Technologies, Llc Enteric softgel capsules

Also Published As

Publication number Publication date
AR121608A1 (es) 2022-06-22
KR20220154196A (ko) 2022-11-21
CO2022014130A2 (es) 2022-10-31
EP4121036A4 (en) 2024-04-10
AU2021238345A1 (en) 2022-10-06
JP2026035788A (ja) 2026-03-04
CA3171512A1 (en) 2022-09-23
WO2021188773A1 (en) 2021-09-23
EP4121036A1 (en) 2023-01-25
US20230172864A1 (en) 2023-06-08
JP7785682B2 (ja) 2025-12-15
MX2022011549A (es) 2022-10-13
JP2023518245A (ja) 2023-04-28

Similar Documents

Publication Publication Date Title
GB0005016D0 (en) PVA-Containing compositions
BR0213924A (pt) Composição polimerizável, polimerizato fotocrÈmico e artigo fotocrÈmico
BR0116701A (pt) Sistema de embalagem para uma lente intraocular e método para implantar uma lente intraocular
BRPI0507320A (pt) máquina e método de enchimento de cápsula relacionada para produção de cápsulas vedadas
BR9912979A (pt) Composição farmacêutica administrável oralmente, tablete de mascar, cápsula e processo para evitar a sìndrome de vazamento anal de óleo
FI944452A0 (fi) Gelatiinikapseli ja menetelmä sen valmistamiseksi
Calzia et al. Effect of polyphenolic phytochemicals on ectopic oxidative phosphorylation in rod outer segments of bovine retina
CO2022007168A2 (es) Cápsulas de gelatina blanda de liberación retardada en ambientes de ph más alto
Maganur et al. Effect of soft drinks and fresh fruit juice on surface roughness of commonly used restorative materials
BR112022018268A2 (pt) Cápsulas de softgel
Fajardo et al. Mitochondrial quality control in the heart: the balance between physiological and pathological stress
ES374925A1 (es) Procedimiento para la preparacion de capsulas de gelatina.
BRPI0415634A (pt) formulação para cápsulas de gelatina macia contendo retinóides
BR0312875A (pt) Cápsula de gelatina resistente à pelìcula
Cruz et al. β Lapachone blocks the cell cycle and induces apoptosis in canine osteosarcoma cells
GB2012378A (en) Mechanical Seals
Bachour et al. Evaluation of the rupture test for stability studies of soft-shell capsules
BRPI0704616A (pt) vedação
Pregadio The Early History of the Zhouyi cantong qi
MY199597A (en) Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules
Espinosa All-Souls Day at Zuñi, Acoma, and Laguna
MX2026001534A (es) Capsula de gelatina suave, y proceso de produccion
GB1272881A (en) Composition containing s-carboxymethyl cysteine
BR112021017876A2 (pt) Estabilidade de api aperfeiçoada em cápsulas gelatinosas
Fernández El florilegio de los mss. FH en la letra Alfa del Florilegio Coisliniano

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]